| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 931,0 k € | +24.9% | 745,5 k € | +36.2% | 547,3 k € | +15.5% | 474,0 k € | -48.9% | 927,8 k € | +0.8% | 920,7 k € | -28.0% | 1,3 M € | +300.6% | 319,3 k € | -22.0% | 409,4 k € | +40.7% | 290,9 k € | +15.7% | 251,4 k € | +64.3% | 153,0 k € | |
| Gross margin | 766,5 k € | +15.4% | 664,1 k € | +26.4% | 525,4 k € | +23.1% | 426,8 k € | -7.6% | 462,1 k € | — | 422,5 k € | +15.3% | 366,5 k € | +5.9% | 345,9 k € | +5.2% | 328,8 k € | +61.7% | 203,3 k € | +116.9% | 93,7 k € | |||
| EBITDA | 33,1 k € | -51.7% | 68,6 k € | +331.6% | -29,6 k € | +57.7% | -70,0 k € | -234.4% | -20,9 k € | +95.5% | -467,0 k € | -838.5% | 63,2 k € | +6.8% | 59,2 k € | -26.4% | 80,5 k € | +515.9% | 13,1 k € | +245.1% | 3,8 k € | +176.1% | -5,0 k € | |
| Operating profit | 33,1 k € | -51.7% | 68,6 k € | +331.6% | -29,6 k € | +57.7% | -70,0 k € | -234.4% | -20,9 k € | +95.5% | -467,0 k € | -838.5% | 63,2 k € | +6.8% | 59,2 k € | -26.4% | 80,5 k € | +515.9% | 13,1 k € | +245.1% | 3,8 k € | +176.1% | -5,0 k € | |
| Profit/loss | 33,3 k € | -51.4% | 68,4 k € | +328.9% | -29,9 k € | +57.3% | -70,0 k € | -234.6% | -20,9 k € | +3.1% | -21,6 k € | -134.2% | 63,2 k € | +6.8% | 59,2 k € | -26.4% | 80,5 k € | +515.9% | 13,1 k € | +245.1% | 3,8 k € | +176.1% | -5,0 k € | |
| Equity | 237,4 k € | +16.3% | 204,1 k € | +50.4% | 135,7 k € | -18.1% | 165,6 k € | -29.7% | 235,6 k € | -8.2% | 256,5 k € | -7.8% | 278,1 k € | +29.4% | 214,9 k € | +38.0% | 155,7 k € | +106.9% | 75,2 k € | +51.5% | 49,7 k € | +153.3% | 19,6 k € | |
| Total assets | 382,3 k € | +22.8% | 311,4 k € | +34.5% | 231,5 k € | -0.5% | 232,6 k € | -44.3% | 417,6 k € | +0.1% | 417,0 k € | -39.4% | 688,3 k € | +2.5% | 671,2 k € | +253.2% | 190,0 k € | +152.5% | 75,2 k € | +51.5% | 49,7 k € | +153.3% | 19,6 k € | |
| Cash | 154,8 k € | +31.9% | 117,4 k € | +81.4% | 64,7 k € | -45.2% | 118,1 k € | -19.0% | 145,9 k € | -27.2% | 200,5 k € | +32.7% | 151,0 k € | -2.6% | 155,0 k € | -18.4% | 190,0 k € | +152.5% | 75,2 k € | +51.5% | 49,7 k € | +153.3% | 19,6 k € | |
| Debts | 144,9 k € | +35.0% | 107,3 k € | +11.9% | 95,9 k € | +42.9% | 67,1 k € | -63.1% | 182,0 k € | +13.4% | 160,5 k € | -60.9% | 410,2 k € | +224.8% | 126,3 k € | +268.1% | 34,3 k € | — | — | — | ||||
| Staff | — | — | — | — | — | 6,5 | 5 | 3,7 | 3,6 | 3,6 | 3,6 | 1,6 | ||||||||||||
Non-profit organization · Saint-Josse-ten-Noode · incorporated on 08/12/2011
Non-profit organization profitable and well capitalised. Cash position rising (+31.9%).
Solid counterparty for a standard engagement.
Antimicrobial Consumption and Resistance in Animals is a Non-profit organization incorporated in 2011. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Saint-Josse-ten-Noode.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette